InsidersTradesSigma
Track the IX BIOPHARMA LTD. share price and the full management transaction log of the company, a listed equity based in Singapore. Shares trade on the SG market, under the oversight of SGX. Market capitalisation: €442.8m. The latest transaction was reported on 26 July 2026 (Purchase). Among the most active insiders: Oversea-Chinese Banking Corporation Limited. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
IX Biopharma Ltd. is a company focused on developing pharmaceutical treatments, emphasizing research and innovation in the biopharmaceutical field.